ClinicalTrialsFinder

Myelodysplastic Syndrome With Excess Blasts-2 Clinical Trials in New Haven, Connecticut

1 recruitingNew Haven, Connecticut

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome With Excess Blasts-2Leukemia, Myeloid, Acute+2 more
Aptose Biosciences Inc.240 enrolled34 locationsNCT03850574